What this means
This trial plans to check signs of aging in older patients with lung cancer. It aims to see if these signs can better predict how patients will do.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 70 and over · Older adults with locally advanced non-small cell lung cancer; no results posted yet, still recruiting
- Where
- 1 site
The science
- Registered title
- Cancer of the Lung And SeneScencE - Prospective Cohort 1
- Trial ID
- NCT06923618 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Non-Small Cell Lung Cancer
- What is tested
- Blood samples
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Ages
- 70 Years to no maximum
- Dates
- First posted Apr 11, 2025 · updated Dec 15, 2025
Registry summary
The main objective is to identify and assess the predictive value of ageing and senescence biomarkers (methylome, telomeres, inflammageing) and senescent cells in tissues to improve prognosis assessment older patients with locally or locally-advanced Non-Small Cell Lung Cancer (NSCLC).
Sites (1)
- Henri Mondor Hospital, Créteil, Île-de-France Region, France